- Email: [email protected]
Contributors to Volume 78
CONTRIBUTORS
Numbers in parentheses indicate the pages on which the authors’ contributions begin.
Anissa Abi-Dargham (1, 133), Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA; Department of Radiology, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA Jean-Michel Arrang (247), INSERM, U573, Unite´ de Neurobiologie et Pharmacologie Mole´culaire Centre Paul Broca, 2 ter rue d’Ale´sia, 75014 Paris, France Joshua A. Berman (193), Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA Ricardo Ca´ceda (327), Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA Deepak Cyril D’Souza (289), Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West-Haven, Connecticut 06516, USA Caroline Demily (377), Unite´ de Psychiatrie, UFR de Me´decine et de Pharmacie de Rouen, France; CHU Ch. Nicolle et Centre Hospitalier du Rouvray, INSERM U614, UFR de Me´decine et de Pharmacie de Rouen, France Robert Freedman (225), Research Service, VA Eastern Colorado Health Care System, Denver, Colorado 80220, USA; Department of Psychiatry, University of Colorado at Denver Health Sciences Center, Denver, Colorado 80262, USA Joseph A. Gogos (397), Department of Physiology and Cellular Biophysics, and Center for Neurobiology and Behavior, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA Yukiori Goto (41), Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA Anthony A. Grace (41), Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA xi
xii
CONTRIBUTORS
Olivier Guillin (1, 377), Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA; Unite´ de Psychiatrie, UFR de Me´dicine et de Pharmacie de Rouen, France Takanori Hashimoto (109), Department of Psychiatry, University of Pittsburgh, Pennsylvania 15213, USA Daniel C. Javitt (69), Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline Institute for Psychiatric Research, New York University School of Medicine, Orangeburg, New York 10962, USA Becky Kinkead (327), Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA Marc Laruelle (1), Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA; Department of Radiology, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA David A. Lewis (109), Department of Psychiatry, University of Pittsburgh, Pennsylvania 15213, USA; Department of Neuroscience, University of Pittsburgh, Pennsylvania 15213, USA Gerard J. Marek (165), Eli Lily and Company, Lilly Research Laboratories, Psychiatric Disorders Discovery Biology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA Laura F. Martin (225), Research Service, VA Eastern Colorado Health Care System, Denver, Colorado 80220, USA; Department of Psychiatry, University of Colorado at Denver Health Sciences Center, Denver, Colorado 80262, USA Charles B. Nemeroff (327), Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA Lorna W. Role (193), Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA; Department of Cell Biology in Pathology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA David A. Talmage (193), Institute of Human Nutrition, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA Florence Thibaut (377), Unite´ de Psychiatrie, UFR de Me´decine et de Pharmacie de Rouen, France; CHU Ch. Nicolle et Centre Hospitalier du Rouvray, INSERM U614, UFR de Me´decine et de Pharmacie de Rouen, France
Numbers in parentheses indicate the pages on which the authors’ contributions begin.
Anissa Abi-Dargham (1, 133), Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA; Department of Radiology, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA Jean-Michel Arrang (247), INSERM, U573, Unite´ de Neurobiologie et Pharmacologie Mole´culaire Centre Paul Broca, 2 ter rue d’Ale´sia, 75014 Paris, France Joshua A. Berman (193), Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA Ricardo Ca´ceda (327), Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA Deepak Cyril D’Souza (289), Department of Psychiatry, Yale University School of Medicine, VA Connecticut Healthcare System, West-Haven, Connecticut 06516, USA Caroline Demily (377), Unite´ de Psychiatrie, UFR de Me´decine et de Pharmacie de Rouen, France; CHU Ch. Nicolle et Centre Hospitalier du Rouvray, INSERM U614, UFR de Me´decine et de Pharmacie de Rouen, France Robert Freedman (225), Research Service, VA Eastern Colorado Health Care System, Denver, Colorado 80220, USA; Department of Psychiatry, University of Colorado at Denver Health Sciences Center, Denver, Colorado 80262, USA Joseph A. Gogos (397), Department of Physiology and Cellular Biophysics, and Center for Neurobiology and Behavior, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA Yukiori Goto (41), Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA Anthony A. Grace (41), Department of Neuroscience, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA xi
xii
CONTRIBUTORS
Olivier Guillin (1, 377), Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA; Unite´ de Psychiatrie, UFR de Me´dicine et de Pharmacie de Rouen, France Takanori Hashimoto (109), Department of Psychiatry, University of Pittsburgh, Pennsylvania 15213, USA Daniel C. Javitt (69), Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline Institute for Psychiatric Research, New York University School of Medicine, Orangeburg, New York 10962, USA Becky Kinkead (327), Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA Marc Laruelle (1), Department of Psychiatry, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA; Department of Radiology, Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University, New York 10032, USA David A. Lewis (109), Department of Psychiatry, University of Pittsburgh, Pennsylvania 15213, USA; Department of Neuroscience, University of Pittsburgh, Pennsylvania 15213, USA Gerard J. Marek (165), Eli Lily and Company, Lilly Research Laboratories, Psychiatric Disorders Discovery Biology, Lilly Corporate Center, Indianapolis, Indiana 46285, USA Laura F. Martin (225), Research Service, VA Eastern Colorado Health Care System, Denver, Colorado 80220, USA; Department of Psychiatry, University of Colorado at Denver Health Sciences Center, Denver, Colorado 80262, USA Charles B. Nemeroff (327), Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA Lorna W. Role (193), Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, New York 10032, USA; Department of Cell Biology in Pathology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA David A. Talmage (193), Institute of Human Nutrition, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA Florence Thibaut (377), Unite´ de Psychiatrie, UFR de Me´decine et de Pharmacie de Rouen, France; CHU Ch. Nicolle et Centre Hospitalier du Rouvray, INSERM U614, UFR de Me´decine et de Pharmacie de Rouen, France